SGHT Q4 2022 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$21M+39.9% YoY

Gross Profit

$17M82.2% margin

Operating Income

-$17M-83.0% margin

Net Income

-$17M-82.3% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+10.0%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$213M

Total Liabilities

$53M

Stockholders' Equity

$160M

Cash & Equivalents

$185M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$15M	+39.9%
Gross Profit	$17M	$13M	+32.4%
Operating Income	-$17M	-$15M	-15.9%
Net Income	-$17M	-$16M	-6.1%

Revenue Segments

Surgical Glaucoma

$19M91%

Dry Eye

$2M9%